Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06953648 · ClinicalTrials.gov registry record · NA
Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant
A NA study, sponsored by University of Kansas Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT06953648 is a NA study that has not yet begun recruiting, run by University of Kansas Medical Center. The registered enrollment target is 126 participants.
The verdict
NCT06953648, a NA study, has not yet begun recruiting, sponsored by University of Kansas Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. The main questions it aims to answer are: Is there a change in the participant's cardiorespiratory fitness level? Is there a change in the participant's physical function? Researchers will compare the REMM-HIIT program to a control group of participants who do not take part in the training program to see if REMM-HIIT helps improve stem cell transplantation outcomes. Participants will: * Complete cardiopulmonary exercise testing (CPET) 4 times during the study * Do basic tests to measure physical function 6 times during the study * Answer questions about their life and how they are feeling 6 times during the study * Wear a device to keep track of step counts and heart rate daily * Keep a log of every time they exercise throughout the study * Optionally, provide blood and stool samples 6 times during the study
Interventions
- BEHAVIORAL High Intensity Interval Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2025-05 |
| Est. Completion | 2030-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06953648
The ClinicalTrials.gov registry entry for NCT06953648 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Intensity Interval Training is the first listed.
NCT06953648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06953648 about?
NCT06953648 is a clinical study titled "Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant". The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. The main questions it aims to answer are: Is there a change in th...
What is the current status of trial NCT06953648?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2025-05. Estimated completion is 2030-03.
What interventions are being tested in trial NCT06953648?
The interventions under investigation include: High Intensity Interval Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06953648?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.